KJHP
ANVS icon

K.J. Harrison & Partners’s Annovis Bio ANVS Stock Holding History

K.J. Harrison & Partners’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,000
Closed -$52K – 240
2020
Q2 		$52K Buy
12,000
+2,000
+20% +$8.26K 0.01% 190
2020
Q1 		$30K Buy
+10,000
New +$49.2K 0.02% 129

Other funds holding ANVS

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

K.J. Harrison & Partners's ANVS Position: Q3 2020 in Review

K.J. Harrison & Partners sold out of Annovis Bio (ANVS) in Q3 2020, closing a stake of 12,000 shares — an estimated $52K sold.

K.J. Harrison & Partners first reported a position in ANVS in Q1 2020 and held it in 2 quarters. The position peaked at $52K in Q2 2020. 12 funds tracked by Wall St. Rank hold ANVS as of Q3 2020.

  • K.J. Harrison & Partners reported no remaining Annovis Bio position as of Q3 2020 after selling out during the quarter.
  • K.J. Harrison & Partners sold 12,000 Annovis Bio shares in Q3 2020, an estimated $52K.
  • K.J. Harrison & Partners first reported a position in Annovis Bio in Q1 2020 and held it in 2 quarters.
  • K.J. Harrison & Partners's Annovis Bio position peaked at $52K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2020.

Based on K.J. Harrison & Partners's 13F filing for Q3 2020, filed 9 Nov 2020.